nChroma Bio - Crunchbase Company Profile & Funding

Q: Who invested in nChroma Bio?

nChroma Bio has 20 investors including Wellington Management And DCVC Bio.

Q: When was the last funding round for nChroma Bio?

nChroma Bio closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has nChroma Bio raised to date?

nChroma Bio has raised obfuscated.

Overview

nChroma Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About nChroma Bio

CB Rank

26261

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

Founded

obfuscation

Private

Venture - Series Unknown

Boston, Massachusetts, United States

51-100

www.nchromabio.com/

Biotechnology

Medical

Product Research

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Noah Goodman: CBO
Melissa Bonner: CSO

Details

Legal Name

nChroma Bio, Inc.

Operating Status

Active

Company Type

For Profit

About the Company

nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques.

Contact Email

info@nchromabio.com

Predictions & Insights

Growth Insight

See this Growth Insight

nChroma Bio is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

CRMA-1001

A liver-targeted epigenetic editing therapy designed to silence hepatitis B and D viral biomarkers for potential functional cure.

Epigenetic Editors Platform

A technology platform for gene regulation that modulates gene expression without altering DNA sequences, enabling reversible and multiplexed gene control.

Research & Development

nChroma Bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown
obfuscated obfuscation	Venture Round - nChroma Bio	20	obfuscated obfuscation	ARCH Venture Partners, Atlas Venture, Cormorant Asset Management, Newpath Management	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Wellington Management	—	Venture Round - nChroma Bio	—
Wellington Management	—	Venture Round - nChroma Bio	—
Wellington Management	—	Venture Round - nChroma Bio	—
Wellington Management	—	Venture Round - nChroma Bio	—
Wellington Management	—	Venture Round - nChroma Bio	—